<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03327168</url>
  </required_header>
  <id_info>
    <org_study_id>T201/2015</org_study_id>
    <nct_id>NCT03327168</nct_id>
  </id_info>
  <brief_title>Adenosine and A2A Receptors in Human Brown Adipose Tissue</brief_title>
  <acronym>AdenoBAT</acronym>
  <official_title>Adenosine and A2a Receptors in Human Brown Adipose Tissue (AdenoBAT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Turku University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Bonn</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Turku University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigates the significance of adenosine and A2A receptors in human brown&#xD;
      adipose tissue (BAT) in vivo. Using positron emission tomography (PET), perfusion and the&#xD;
      density of A2A receptors will be measured in supraclavicular BAT and other tissues in healthy&#xD;
      men. The investigators hypothesize, that adenosine can activate BAT, and that adenosine A2A&#xD;
      receptor density changes when BAT is activated by cold exposure.&#xD;
&#xD;
      Understanding the mechanisms of BAT activation and the role of endocannabinoids in humans is&#xD;
      important and beneficial in fighting against the epidemic of obesity and diabetes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Adenosine is a purine nucleoside released locally in BAT when noradrenaline and ATP are&#xD;
      released from sympathetic nerves. Recently it was found that adenosine activates murine and&#xD;
      human brown adipocytes, and recruits beiging of white fat via adenosine A2A receptors (A2AR).&#xD;
      Furthermore, studies with mice have shown improvements in glucose homeostasis after&#xD;
      administration of A2AR agonists.&#xD;
&#xD;
      In this study the investigators use the PET radiotracer [15O]-H2O to quantify perfusion of&#xD;
      BAT, white adipose tissue (WAT) and muscle in three conditions: room temperature, cold&#xD;
      exposure and intravenous infusion of adenosine. Another PET radiotracer [11C]TMSX is used to&#xD;
      quantify adenosine A2A receptor density of BAT, WAT and muscle in room temperature and during&#xD;
      cold exposure.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 1, 2015</start_date>
  <completion_date type="Actual">June 30, 2016</completion_date>
  <primary_completion_date type="Actual">June 30, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Each subject participates in PET/CT scans in room temperature conditions, during cold exposure and during i.v. infusion of adenosine.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>BAT perfusion</measure>
    <time_frame>Effect within 10 minutes</time_frame>
    <description>Perfusion of BAT with [15O]-H2O PET-CT</description>
  </primary_outcome>
  <primary_outcome>
    <measure>A2A receptor density in BAT</measure>
    <time_frame>Effect within 3 hours</time_frame>
    <description>Density of A2A receptors in BAT measured with [11C]-TMSX PET/CT</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">11</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Adenosine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Perfusion is measured using PET/CT during intravenous infusion (0.14 mg/kg/min) of adenosine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Room temperature</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Perfusion and A2A receptor density is measured using PET/CT in resting room temperature conditions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cold exposure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Perfusion and A2A receptor density is measured using PET/CT during controlled cold exposure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Adenosine</intervention_name>
    <description>Intravenous infusion of adenosine (0.14 mg/kg) is administered for 5 minutes during PET/CT scan.</description>
    <arm_group_label>Adenosine</arm_group_label>
    <other_name>Adenocor</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cold exposure</intervention_name>
    <description>Controlled cold exposure is performed before and during PET/CT scan.</description>
    <arm_group_label>Cold exposure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Male sex&#xD;
&#xD;
          2. BMI 20 - 28 kg/m2&#xD;
&#xD;
          3. Age: 18- 40 years&#xD;
&#xD;
          4. Normal OGTT&#xD;
&#xD;
          5. Healthy, no regular medication&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. BMI &lt; 20 kg/m2 or BMI &gt; 28 kg/m2&#xD;
&#xD;
          2. Low or high blood pressure&#xD;
&#xD;
          3. Asthma or other obstructive lung disease&#xD;
&#xD;
          4. Sick sinus syndrome, prolonged QT-interval, or any heart disease&#xD;
&#xD;
          5. Any chronic disease that could affect the study outcome, including diabetes&#xD;
&#xD;
          6. Mental disorder or poor compliance&#xD;
&#xD;
          7. Eating disorder or excessive use of alcohol, tobacco smoking or drug use&#xD;
&#xD;
          8. Past dose of radiation&#xD;
&#xD;
          9. Any other condition that in the opinion of the investigator could create a hazard to&#xD;
             the subject safety, endanger the study procedures or interfere with the interpretation&#xD;
             of study results&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kirsi A Virtanen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Turku University Hospital</affiliation>
  </overall_official>
  <verification_date>October 2017</verification_date>
  <study_first_submitted>September 28, 2017</study_first_submitted>
  <study_first_submitted_qc>October 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 31, 2017</study_first_posted>
  <last_update_submitted>October 31, 2017</last_update_submitted>
  <last_update_submitted_qc>October 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Turku University Hospital</investigator_affiliation>
    <investigator_full_name>Kirsi Virtanen</investigator_full_name>
    <investigator_title>Adjunct Professor</investigator_title>
  </responsible_party>
  <keyword>Adipose Tissue, Brown</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenosine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

